Incidence of acute serious bacterial infections one year [clinicaltrials_resource:c09e2c3a05550972b0288b7799fcb94c]
Acute serious bacterial infections are defined in The FDA(CBER) Guidance for industry for studies of IGIV to support marketing of IGIV as replacement therapy for primary humoral immunodeficiency (June, 2008).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Incidence of acute serious bacterial infections one year [clinicaltrials_resource:c09e2c3a05550972b0288b7799fcb94c]
Acute serious bacterial infections are defined in The FDA(CBER) Guidance for industry for studies of IGIV to support marketing of IGIV as replacement therapy for primary humoral immunodeficiency (June, 2008).
Bio2RDF identifier
c09e2c3a05550972b0288b7799fcb94c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c09e2c3a05550972b0288b7799fcb94c
measure [clinicaltrials_vocabulary:measure]
Incidence of acute serious bacterial infections
time frame [clinicaltrials_vocabulary:time-frame]
description
Acute serious bacterial infect ...... immunodeficiency (June, 2008).
identifier
clinicaltrials_resource:c09e2c3a05550972b0288b7799fcb94c
title
Incidence of acute serious bacterial infections one year
@en
type
label
Incidence of acute serious bac ...... e2c3a05550972b0288b7799fcb94c]
@en